Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- T cell activation
- Dendritic cells (DC)
- Immune activation (1)
- Pattern recognition
- Bug recognition by Toll-like receptors in mammals
- PRRs: coupling innate and adaptive immunity
- Immune activation (2)
- Viruses induce type I/III interferons
- Induction of type I interferons is pattern recognition
- Pattern recognition of viruses
- IFN-alpha production and cytoplasmic dsRNA
- IFN-alpha/beta induction by cytoplasmic dsRNA
- Influenza virus
- Influenza NS1 protein blocks IFN-a/b production
- Cytoplasmic recognition of flu
- Induction of IFN-a does not correlate with dsRNA
- RIG-I mediated flu sensing
- Transfection with flu vRNA is sufficient to elicit IFN
- RIG-I binds directly to flu vRNA
- RIG-I mediated sensing of flu genomes
- Induction of type I/III interferons
- Recognition is specific to vRNA
- CIP abrogates the ability of flu vRNA to induce IFN
- Conclusions (1)
- 5' PPP RNA binds to the CTD of RIG-I
- Why RIG-I doesn't mediate responses to EMCV
- What about self ssRNA?
- The actual RIG-I agonist during virus infection
- IFN-a/b induction by viruses - Cytosolic pathways
- Mouse DC subsets
- pDC make lots of IFN-a in response to wild type flu
- Conclusions (2)
- pDC responses to flu require TLR7
- Endosomal recognition of viruses
- Virus recognition pathways
- TLR7 recognises poly U clusters
- TLR7 recognises self mRNA
- Conclusions (3)
- What about apoptotic cells? (1)
- Spleen DC subsets
- Scavenging by CD8-alpha positive DC
- What about apoptotic cells? (2)
- CD8a+ DC do not express TLR7 but express TLR3
- DC "decode" signs of infection within dying cells
- Detecting virally-infected cells
- Replication of some viruses generates dsRNA
- DC activation by virally-infected cells
- Virus-infected cells induce CTL responses
- CTL priming after TLR3-mediated dsRNA sensing
- Summary
- Acknowledgements
Topics Covered
- Induction of the adaptive Immunity
- Pattern recognition receptors: coupling innate to adaptive immunity
- Induction of type I IFNs: an example of recognition of viral patterns
- Cytosolic pathway for influenza virus recognition and inhibition by the viral
- NSI protein
- RIG-I-mediated recognition of influenza virus genomes and 5'-PPP-RNA
- Cytosolic 5'-PPP-RNA as a PAMP
- Plasmacytoid DC and the discovery of a second pathway for innate recognition of influenza virus
- Endosomal pathways for virus recognition: TLR7, TLR9
- TLR3 as a sensor of virally-infected cells
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
e Sousa, C.R. (2009, June 30). Innate recognition of viruses [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/UTCF7401.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Caetano Reis e Sousa has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.